Innoviva, Inc. (INVA)
21.39
+0.31
(+1.47%)
USD |
NASDAQ |
Sep 02, 13:15
Innoviva Net Income (TTM) : 357.24M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 357.24M |
| March 31, 2026 | 504.34M |
| December 31, 2025 | 271.16M |
| September 30, 2025 | 127.34M |
| June 30, 2025 | 38.65M |
| March 31, 2025 | -59.72M |
| December 31, 2024 | 23.39M |
| September 30, 2024 | 64.59M |
| June 30, 2024 | 145.42M |
| March 31, 2024 | 181.39M |
| December 31, 2023 | 179.72M |
| September 30, 2023 | 49.88M |
| June 30, 2023 | 197.18M |
| March 31, 2023 | 217.27M |
| December 31, 2022 | 220.26M |
| September 30, 2022 | 334.23M |
| June 30, 2022 | 207.52M |
| March 31, 2022 | 297.00M |
| December 31, 2021 | 368.84M |
| September 30, 2021 | 398.20M |
| June 30, 2021 | 337.18M |
| March 31, 2021 | 324.56M |
| December 31, 2020 | 293.81M |
| September 30, 2020 | 276.66M |
| June 30, 2020 | 282.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 229.93M |
| December 31, 2019 | 190.99M |
| September 30, 2019 | 402.35M |
| June 30, 2019 | 405.46M |
| March 31, 2019 | 416.02M |
| December 31, 2018 | 406.33M |
| September 30, 2018 | 195.63M |
| June 30, 2018 | 169.23M |
| March 31, 2018 | 147.76M |
| December 31, 2017 | 134.27M |
| September 30, 2017 | 101.23M |
| June 30, 2017 | 92.49M |
| March 31, 2017 | 71.94M |
| December 31, 2016 | 59.54M |
| September 30, 2016 | 38.37M |
| June 30, 2016 | 18.75M |
| March 31, 2016 | -3.658M |
| December 31, 2015 | -18.76M |
| September 30, 2015 | -38.99M |
| June 30, 2015 | -55.67M |
| March 31, 2015 | -68.02M |
| December 31, 2014 | -125.05M |
| September 30, 2014 | -159.05M |
| June 30, 2014 | -184.77M |
| March 31, 2014 | -201.05M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Zevra Therapeutics, Inc. | 56.00M |
| Collegium Pharmaceutical, Inc. | 47.92M |
| CorMedix, Inc. | 187.17M |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 54.20M |